P-163: Efficacy and safety of Daratumumab, Bortezomib, Melphalan, and Prednisone (D-VMP) versus Bortezomib, Melphalan, and Prednisone (VMP) in Chinese patients with newly diagnosed Multiple Myeloma: OCTANS
暂无分享,去创建一个
Jianxiang Wang | Z. Cai | Wei Li | M. Qi | G. An | Jianping Wang | C. Chim | W. Fu | Yunan Li | Jie Jin | Honghui Huang | Wenyu Liu | Renyi Zhang | J. Hou | Xue Yang | Yafei Wang | B. Jia | Yang Song